Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05818462 · ClinicalTrials.gov registry record
Bladder and Bone Effects of Pelvic Radiation Therapy in Childhood Cancer Survivors
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 32
- Enrollment target
NCT05818462: Completed study, sponsored by University of Colorado, Denver.
NCT05818462 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05818462 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The aim of this study is to measure and evaluate the effects of pelvic external beam radiation therapy (EBRT) on lower urinary tract (LUT) function and bone mineralization.
Primary Outcome
aggregate measured by voiding time (seconds, s), total voided volume (mL), average uroflow rate (mL/s), maximum uroflow rate (mL/s), uroflow pattern or curve (bell-shaped, tower-shaped, staccato, interrupted or plateau), and post void residual (mL)
Interventions
- DIAGNOSTIC_TEST Uroflow testing
- DIAGNOSTIC_TEST Bladder Scan
- OTHER Dysfunctional Voiding Scoring System Survey
- DIAGNOSTIC_TEST DEXA Scan of pelvis and sacral spine
- DIAGNOSTIC_TEST Urine tests for specific biomarkers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2023-07-11 |
| Est. Completion | 2025-05-02 |
What the finished NCT05818462 record still lists
NCT05818462 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which Uroflow testing is the first listed.
NCT05818462 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05818462 about?
NCT05818462 is a clinical study titled "Bladder and Bone Effects of Pelvic Radiation Therapy in Childhood Cancer Survivors". The aim of this study is to measure and evaluate the effects of pelvic external beam radiation therapy (EBRT) on lower urinary tract (LUT) function and bone mineralization.
What is the current status of trial NCT05818462?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2023-07-11. Estimated completion is 2025-05-02.
What interventions are being tested in trial NCT05818462?
The interventions under investigation include: Uroflow testing (DIAGNOSTIC_TEST), Bladder Scan (DIAGNOSTIC_TEST), Dysfunctional Voiding Scoring System Survey (OTHER), DEXA Scan of pelvis and sacral spine (DIAGNOSTIC_TEST), Urine tests for specific biomarkers (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05818462?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI